Back to search
FDAFDA · Food and drugs·Recall number D-1142-2017

ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8

Published September 20, 2017 · Recall initiated: June 6, 2017

Summary

FDA records drug Class I recall D-1142-2017, published September 20, 2017 and initiated June 6, 2017. Recalling firm: Andropharm, LLC; Status: Terminated; Reported quantity: 150 bottles; Lot: All lots remaining within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Andropharm, LLC
Distributor
Florida
Lot
All lots remaining within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8 recalled?

Yes. FDA published recall D-1142-2017 on September 20, 2017. Reported hazard: Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.

What should I do if I have this product?

Voluntary: Firm initiated · Letter